Concepedia

Author

Cato Mørk

Oslo University HospitalORCID

Also Known As

C Mork, C Mørk, C. MOrk, C. Mork, C. Mørk, C.M. Mork, Caroline M. Mork, Caroline Mae Mork, Cato Mork, Cato Mørk

90

Publications

3.6K

Citations

29

H-Index

67

Concepts

All Affiliations

Oslo University HospitalUniversity of OsloDiakonhjemmet HospitalAkershus University HospitalNorwegian University of Science and Technology
CM

About

Cato Mørk is an author at Oslo University Hospital specializing in medicine, dermatology, and psoriatic arthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

16

1.3K

2

Health Sciences

5

5

970

3

Allergy

2

2

89

4

Natural Sciences

1

1

18

5

Social Sciences

1

1

11

Cato Mørk

×

35

Publications

2.9K

Citations

24

H-Index

YearCitations

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll,

The Lancet

2017

789

Quality of Life and Prevalence of Arthritis Reported by 5,795 Members of the Nordic Psoriasis Associations

H Zachariae, Robert Zachariae, K Blomqvist,

Acta Dermato Venereologica

2002

219

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp

Stine Regin Wiegell, Susanne Fabricius, Ida‐Marie Stender,

British Journal of Dermatology

2011

171

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll,

JAMA

2021

147

Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study

Stine Regin Wiegell, Susanne Fabricius, Monika Gniadecka,

British Journal of Dermatology

2012

146

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen,

JAMA

2021

117

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

Guro Løvik Goll, Kristin Kaasen Jørgensen, J. Sexton,

Journal of Internal Medicine

2019

116

Self‐reported stress reactivity and psoriasis‐related stress of Nordic psoriasis sufferers

Robert Zachariae, H Zachariae, K Blomqvist,

Journal of the European Academy of Dermatology and Venereology

2003

105

Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series

Deniz Seçkin, Stéphane Barète, Sylvie Euvrard,

American Journal of Transplantation

2013

87

Microvascular Arteriovenous Shunting is a Probable Pathogenetic Mechanism in Erythromelalgia

Cato Mørk, Claes Asker, E. Göran Salerud,

Journal of Investigative Dermatology

2000

83

Page 1